Monoamine oxidase inhibitors revisited: what you should know

J Clin Psychiatry. 2013 Feb;74(2):189-91. doi: 10.4088/JCP.12ac08299.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Depressive Disorder / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Isocarboxazid / administration & dosage
  • Isocarboxazid / therapeutic use
  • Monoamine Oxidase Inhibitors / administration & dosage
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Phenelzine / administration & dosage
  • Phenelzine / therapeutic use
  • Selegiline / administration & dosage
  • Selegiline / therapeutic use
  • Tranylcypromine / administration & dosage
  • Tranylcypromine / therapeutic use
  • Tyramine / physiology

Substances

  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • Selegiline
  • Isocarboxazid
  • Tranylcypromine
  • Phenelzine
  • Tyramine